Order Supplies / REQ Forms

Order All Testing
Supplies Here

MyBestMed®

Click to read our Informed Consent information


PGx Req Forms 10.31.22(All three needed forms combined)

Chain of Custody Record 11.11.22


Letter of Medical Necessity 4.26.22

Instruction Forms


MyBestMed Instructions V.1 4.29.22

ICD-10 Codes 6.19.23

RPP (Respiratory Pathogen Panel)/Covid-19


Chain of Custody Record 11.11.22

Skilled Nursing Order 10.31.22

Wellness and Pain Management – Toxicology Solutions


Chain of Custody Record 11.11.22



Req Form Urine 10.31.22

Instruction Forms


Oral-Eze Specimen Collection Instructions V.1 4.29.22

Informed Consent

PHARMACOGENOMIC TESTING: INFORMED CONSENT

We recommend that you consult with your physician or healthcare provider or obtain professional genetic counseling prior to consenting to MyBestMed® pharmacogenetic testing. You can find more information about MyBestMed® at www.ProGeneX.com or contact Pro-GeneX Laboratories, Inc. at (844) 794-3637. In some states, it is unlawful for an entity to obtain your biological sample to conduct testing without first obtaining your informed consent. This is additional information you need to consent to pharmacogenetic testing.

Information about Pharmacogentic Testing:

  • Participation in MyBestMed® testing is completely voluntary.
  • You must provide a biological sample for this test to be performed; the sample will be obtained via an oral swab, which is non-invasive and possess very little risk to your health.
  • Your biological sample will be used for the purpose of obtaining MyBestMed® results that may determine how your body interacts with certain pharmaceuticals/medications.
  • A positive result is an indication that you may be predisposed to or have a specific condition related to the use of certain pharmaceuticals/medications. Further testing and/or consultation with a healthcare provider or genetic counselor may be needed to confirm or understand your results.
  • The tests offered are the best available at this time. MyBestMed® testing is complex and utilizes specialized materials; however, there is always a small chance an error may occur.
  • Due to limitations in technology and incomplete knowledge of genes, some changes in DNA or protein products that cause interactions with pharmaceuticals may not be detected by the test.
  • There may be a possibility that the laboratory findings will be uninterpretable or of unknown significance.
  • Pro-GeneX will not disclose your results to anyone other than you and the healthcare provider that ordered your test.
    Your test results will not be disclosed to any person, entity, or employer unless you authorize such a release in
    writing, or a disclosure is required by law, or ordered by a court for legal proceedings or investigation. Only persons within our company or under contract with our company who have a need to know about your testing and your test results will have access to your information unless one of the aforementioned situations apply.
  • Your personal information, excluding test results, may be disclosed to your insurer if you supply health insurance information & Pro-GeneX or your healthcare provider seek reimbursement from your insurer for this test.
  • Your electronic tests results will be provided to your healthcare provider within 10 days of processing your sample.
  • Your biological sample will only be used for the MyBestMed® testing as authorized by this consent. There will be no tests performed on your biological sample other than MyBestMed® testing except such testing that is necessary or required to demonstrate the integrity of the sample tested or to resolve the analysis of a test with a previously indeterminate result performed on your biological sample.
  • Pro-GeneX does not retain your biological sample; your sample will be destroyed within 60 days of the date of testing.

Click to download the complete Informed Consent form.

You Might Also Like

MyBestMed® | News
How to use the Pro-Genex Pharmacogenetic test.

We hope this video helps you to understand how to administer the Pro-GeneX Pharmacogenetic test. Cheek (buccal) cells will be collected by swabbing the inside of your cheeks. Pay attention not to

Read more >
Toxicology Solutions | News
In toxicology, unraveling the unexpected positives

Amy Carpenter Aquino December 2022—In toxicology testing, cross-reactive compounds, incomplete medical records, immunoassay performance, calibrator drift, and human error all play into unexpected positives. “Always be critical of your testing. Be hard

Read more >
MyBestMed® | News
Clinical use of pre-emptive pharmacogenetic programmes

The clinical implementation of pharmacogenetics (the study of how genetics influence individual variations in drug response) is a key factor in the development of programmes to prevent adverse drug reactions. Yet pharmacogenetics

Read more >
MyBestMed®, Video | News
Demonstrating the Value of Clinical Laboratory Medicine: Impact of Pharmacogenetic Panel Testing on a Health Plan

As healthcare costs continue to climb in the United States, drug costs are responsible for a disproportionate percentage of the overall healthcare spend. Pharmacogenetic testing has been scientifically validated as an option

Read more >